[1]
|
Brunner, B., Hoeck, M., Schermer, E., et al. (2013) Patent Ductus Arteriosus, Low Platelets, Cyclooxygenase Inhibitors, and intraventricular Hemorrhage in Very Low Birth Weight Preterm Infants. The Journal of Pediatrics, 163, 23-28. https://doi.org/10.1016/j.jpeds.2012.12.035
|
[2]
|
Karakurtn, N., Uslu, I., Albayrak, C., et al. (2018) Neonates Born to Mothers with Immune Thrombocytopenia: 11 Years Experience of a Single Academic Center. Blood Coagulation & Fibrinolysis, 29, 546-550.
https://doi.org/10.1097/MBC.0000000000000758
|
[3]
|
Venkatesh, V., Curley, A., Khan, R., et al. (2013) A Novel Approach to Standardised Recording of Bleeding in a High Risk Neonatal Population. ADC Fetal & Neonatal Edition, 98, F260-F263.
https://doi.org/10.1136/archdischild-2012-302443
|
[4]
|
Boutaybi, N., Steggerda, S.J., Smits-Wintjens, V.E.H.J., et al. (2013) Early-Onset Thrombocytopenia in Near-Term and Term Infants with Perinatal Asphyxia. Vox Sanguinis, 106, 361-367. https://doi.org/10.1111/vox.12105
|
[5]
|
Bussel, J.B., de Miguel, P.G., Despotovic, J.M., et al. (2015) Eltrombopag for the Treatment of Children with Persistent and Chronic Immune Thrombocytopenia (PETIT): A Randomised, Multicentre, Placebo-Controlled Study. The Lancet Haematology, 2, E315-E325. https://doi.org/10.1016/S2352-3026(15)00114-3
|
[6]
|
肖秀漫, 江程程, 姜娜, 等. 新生儿血小板减少症259例临床分析[J]. 医学研究杂志, 2016, 45(11): 124-128.
|
[7]
|
Delbos, F., Bertrand, G., Croisille, L., Ansart-Pirenne, H., Bierling, P. and Kaplan, C. (2016) Fetal and Neonatal Alloimmune Thrombocytopenia: Predictive Factors of Intracranial Hemorrhage. Transfusion, 56, 59-66.
https://doi.org/10.1111/trf.13274
|
[8]
|
Zdravic, D., Yougbare, I., Vadaszb, B., et al. (2016) Fetal and Neonatal Alloimmune Thrombocytopenia. Seminars in Fetal & Neonatal Medicine, 21, 19-27. https://doi.org/10.1016/j.siny.2015.12.004
|
[9]
|
蒋亚君, 陈师, 王雪秋, 等. 足月小样儿早发型血小板减少症围生期危险因素配对对照研究[J]. 临床儿科杂志, 2018, 36(1): 40-43+60.
|
[10]
|
Bayhan, T., Tavil, B., Korkmaz, A., et al. (2016) Neonates Born to Mothers with Immune Thrombocytopenic Purpura: A Single-Center Experience of 20 Years. Blood Coagulation & Fibrinolysis, 27, 19-23.
https://doi.org/10.1097/MBC.0000000000000378
|
[11]
|
Koyama, S., Tomimatsu, T., Kanagawa, T., et al. (2012) Reliable Predictors of Neonatal Immune Thrombocytopenia in Pregnant Women with Idiopathic Thrombocytopenic Purpura. American Journal of Hematology, 87, 15-21.
https://doi.org/10.1002/ajh.22178
|
[12]
|
Manukjan, G., Bosing, H., Schmugge, M., et al. (2017) Impact of Genetic Variants on Haematopoiesis in Patients with Thrombocytopenia Absent Radii (TAR) Syndrome. British Journal of Haematology, 179, 606-617.
https://doi.org/10.1111/bjh.14913
|
[13]
|
Kumarm, K., Chaudhary, I.P., Ranjan, R.B., et al. (2015) Thrombocytopenia with Unilateral Dysplastic Radius—Is It Thrombocytopenia-Absent Radius (TAR) Syndrome? Journal of Clinical and Diagnostic Research, 9, SD01-SD02.
https://doi.org/10.7860/JCDR/2015/12263.5626
|
[14]
|
Alter, B.P. (2014) Fanconi Anemia and the Development of Leukemia. Best Practice & Research Clinical Haematology, 27, 214-221. https://doi.org/10.1016/j.beha.2014.10.002
|
[15]
|
Newman, L.A., Luter, M.A., Davis, D.B., et al. (2017) Congenital Amegakaryocytic Thrombocytopenia: A Case Series Indicating 2 Founder Variants in the Mississippi Band of Choctaw Indians. Journal of Pediatric Hematology/Oncology, 39, 573-575. https://doi.org/10.1097/MPH.0000000000000904
|
[16]
|
Zhang, Y.N. and Zhang, Q. (2017) Research Progress in Congenital Amegakaryocytic Thrombocytopenia. Chinese Journal of Pediatrics, 55, 155-158.
|
[17]
|
Liu, N., Shi, H., Kong, X., et al. (2014) Mutation Analysis of WASP Gene and Prenatal Diagnosis of Wiskott-Aldrich Syndrome. Chinese Journal of Pediatrics, 52, 662-666.
|
[18]
|
Rajagopal, R., Thachil, J. and Monagle, P. (2017) Disseminated Intravascular Coagulation in Paediatrics. Archives of Disease in Childhood, 102, 187-193. https://doi.org/10.1136/archdischild-2016-311053
|
[19]
|
Saxonhouse, M.A. (2015) Thrombosis in the Neonatal Intensive Care Unit. Clinics in Perinatology, 42, 651-673.
https://doi.org/10.1016/j.clp.2015.04.010
|
[20]
|
Kjeldsen-Kragh, J., Titze, T.L., Lie, B.A., Vaage, J.T. and Kjær, M. (2019) HLA-DRB3*01:01 Exhibits a Dose-Dependent Impact on HPA-1a Antibody Levels in HPA-1a-Immunized Women. Blood Advances, 3, 945-951.
https://doi.org/10.1182/bloodadvances.2019032227
|
[21]
|
Tarantino, M.D., Bussel, J.B., Blanchette, V.S., et al. (2016) Romiplostim in Children with Immune Thrombocytopenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study. The Lancet, 388, 45-54.
https://doi.org/10.1016/S0140-6736(16)00279-8
|
[22]
|
Lieberman, L., Greinacher, A., Murphy, M.F., et al. (2019) International Collaboration for Transfusion Medicine Guidelines (ICTMG). Fetal and Neonatal Alloimmune Thrombocytopenia: Recommendations for Evidence-Based Practice, an International Approach. British Journal of Haematology, 185, 549-562. https://doi.org/10.1111/bjh.15813
|
[23]
|
Bussel, J.B., Arnold, D.M., Boxer, M.A., et al. (2019) Long-Term Fostamatinib Treatment of Adults with Immune Thrombocytopenia during the Phase 3 Clinical Trial Program. American Journal of Hematology, 94, 546-553.
https://doi.org/10.1002/ajh.25444
|
[24]
|
Akman, A.O., Kara, F.K., Koksal, T., Cakir, B.C., Karagol, C. and Sayli, T. (2017) Association of Hemolysis with High Dose Intravenous Immunoglobulin Therapy in Pediatric Patients: An Open-Label Prospective Trial. Transfusion and Apheresis Science, 56, 531-534. https://doi.org/10.1016/j.transci.2017.07.022
|
[25]
|
Baker, J., Shehata, N., Murphy, M.F., Greinacher, A., Bakchoul, T., Massey, E., Lieberman, L., Landry, D., Tanael, S., Arnold, D.M., Baidya, S., Bertrand, G., Bussel, J., Kjaer, M., Kaplan, C., Kjeldsen-Kragh, J., Oepkes, D., Savoia, H., Ryan, G. and Hume, H. (2018) Postnatal Intervention for the Treatment of Fetal and Neonatal Alloimmune Thrombocytopenia: A Systematic Review. Vox Sanguinis, 113, 113-118.
|
[26]
|
Newland, A., Godeau, B., Priego, V., et al. (2016) Remission and Platelet Responses with Romiplostim in Primary Immune Thrombocytopenia: Final Results from a Phase 2 Study. British Journal of Haematology, 172, 262-273.
https://doi.org/10.1111/bjh.13827
|
[27]
|
Ahmed, R., Devasia, A.J., Viswabandya, A., et al. (2016) Long-Term Outcome Following Splenectomy for Chronic and Persistent Immune Thrombocytopenia (ITP) in Adults and Children: Splenectomy in ITP. Annals of Hematology, 95, 1429-1434. https://doi.org/10.1007/s00277-016-2738-3
|
[28]
|
Leadford, A.E., Warren, J.B., Manasyan, A., Chomba, E., Salas, A.A., Schelonka, R., et al. (2013) Plastic Bags for Prevention of Hypothermia in Preterm and Low Birthweight Infants. Pediatrics, 132, e128-134.
https://doi.org/10.1542/peds.2012-2030
|
[29]
|
Boulton, F. (2004) Transfusion Guidelines for Neonates and Older Children. British Journal of Haematology, 124, 433-453. https://doi.org/10.1111/j.1365-2141.2004.04815.x
|
[30]
|
Zheng, D., Huang, C.S., Huang, S.B. and Zheng, C.X. (2016) Laparoscopic Splenectomy for Primary Immune Thrombocytopenia: Current Status and Challenges. World Journal of Gastrointestinal Endoscopy, 8, 610-615.
https://doi.org/10.4253/wjge.v8.i17.610
|
[31]
|
Tiller, H., Husebekk, A., Ahlen, M.T., et al. (2017) Current Perspectives on Fetal and Neonatal Alloimmune Thrombocytopenia—Increasing Clinical Concerns and New Treatment Opportunities. International Journal of Women’s Health, 9, 223-234. https://doi.org/10.2147/IJWH.S90753
|
[32]
|
Regan, F., Lees, C.C., Jones, B., et al. (2019) Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No.61. BJOG: An International Journal of Obstetrics & Gynaecology, 126, e173-e185. https://doi.org/10.1111/1471-0528.15642
|
[33]
|
Petermann, R., Bakchoul, T., Curtis, B.R., et al. (2018) Investigations for Fetal and Neonatal Alloimmune Thrombocytopenia: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 16, 2526- 2529.
https://doi.org/10.1111/jth.14294
|
[34]
|
Benjamin, R.J., Dy, B., Perez, J., et al. (2014) Bacterial Culture of Apheresis Platelets: A Mathematical Model of the Residual Rate of Contamination Based on Unconfirmed Positive Results. Vox Sanguinis, 106, 23-30.
https://doi.org/10.1111/vox.12065
|
[35]
|
郝欣欣, 邓晶, 丛桂敏, 等. 胎儿/新生儿同种免疫性血小板减少症的诊断——附1例并文献复习[J]. 中国输血杂志, 2020, 33(11): 1167-1172.
|
[36]
|
Estcourt, L.J., Birchall, J., Allard, S., et al. (2017) Guidelines for the Use of Platelet Transfusions. British Journal of Haematology, 176, 365-394. https://doi.org/10.1111/bjh.14423
|
[37]
|
Hutchinson, A.L., Dennington, P.M., Holdsworth, R., et al. (2015) Recurrent HLA-B56 Mediated Neonatal Alloimmune Thrombocytopenia with Fatal Outcomes. Transfusion and Apheresis Science, 52, 311-313.
https://doi.org/10.1016/j.transci.2015.01.007
|
[38]
|
Sachs, U.J., Wienzek-Lischka, S., Duong, Y., et al. (2020) Maternal Anti-Bodies against Paternal Class I Human Leukocyte Antigens Are Not Associated with Foetal and Neonatal Alloimmune Thrombocytopenia. British Journal of Haematology, 189, 751-759. https://doi.org/10.1111/bjh.16419
|
[39]
|
Curtis, B.R. (2015) Recent Progress in Understanding the Pathogenesis of Fetal and Neonatal Alloimmune Thrombocytopenia. British Journal of Haematology, 171, 671-682. https://doi.org/10.1111/bjh.13639
|
[40]
|
马德冉, 赵莉, 田野, 等. 6例新生儿同种免疫性血小板减少症临床资料回顾分析[J]. 中国输血杂志, 2020, 33(10): 1026-1028.
|